Pages that link to "Q80346005"
Jump to navigation
Jump to search
The following pages link to Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade (Q80346005):
Displaying 50 items.
- Molecular pathology of prostate cancer (Q24672410) (← links)
- Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer (Q24677026) (← links)
- Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer (Q26747008) (← links)
- Signal transducer and activator of transcription 5A/B in prostate and breast cancers (Q28281791) (← links)
- Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma (Q30405446) (← links)
- Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter (Q30416775) (← links)
- The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. (Q33412361) (← links)
- Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth. (Q33745272) (← links)
- Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features (Q34066293) (← links)
- Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors (Q34093594) (← links)
- Effects of metoclopramide on mRNA levels of steroid 5α-reductase isozymes in prostate of adult rats (Q34340725) (← links)
- Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer (Q34344798) (← links)
- Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer (Q34363785) (← links)
- What can we learn from rodents about prolactin in humans? (Q34721567) (← links)
- Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications (Q34768155) (← links)
- Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. (Q35000190) (← links)
- Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer (Q35012937) (← links)
- Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia (Q35025251) (← links)
- Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1 (Q35083529) (← links)
- Estrogen action and prostate cancer (Q35099011) (← links)
- Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer (Q35186472) (← links)
- Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. (Q35646876) (← links)
- BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability (Q35677312) (← links)
- Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer. (Q35685196) (← links)
- Erythropoietin modulation of podocalyxin and a proposed erythroblast niche (Q35900969) (← links)
- Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer (Q35971094) (← links)
- Serum biomarker profiles as diagnostic tools in lung cancer (Q36016138) (← links)
- Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer (Q36134471) (← links)
- Constitutive activation of signal transducer and activator of transcription 5 contributes to tumor growth, epithelial-mesenchymal transition, and resistance to epidermal growth factor receptor targeting (Q36175369) (← links)
- Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway (Q36297949) (← links)
- Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer (Q36304018) (← links)
- Tuning of alternative splicing--switch from proto-oncogene to tumor suppressor (Q36503982) (← links)
- Prolactin gene expression in primary central nervous system tumors (Q36556489) (← links)
- Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? (Q36615933) (← links)
- Nonreceptor tyrosine kinases in prostate cancer (Q36759212) (← links)
- Cancer cell signaling pathways targeted by spice-derived nutraceuticals (Q36819371) (← links)
- Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians. (Q36859140) (← links)
- Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer (Q36884424) (← links)
- STAT5A/B gene locus undergoes amplification during human prostate cancer progression (Q36888336) (← links)
- Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor. (Q36944559) (← links)
- Rational design of competitive prolactin/growth hormone receptor antagonists (Q37064937) (← links)
- Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo (Q37269431) (← links)
- Antagonizing STAT5B dimerization with an osmium complex (Q37419916) (← links)
- Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles (Q37709535) (← links)
- The role of Stat5 transcription factors as tumor suppressors or oncogenes (Q37802462) (← links)
- Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer (Q37854477) (← links)
- Prolactin regulation of the prostate gland: a female player in a male game (Q37942413) (← links)
- Targeting tumor hypoxia in nasopharyngeal carcinoma. (Q37959387) (← links)
- Molecular pathways in prostate cancer (Q38166735) (← links)
- Prolactin-induced prostate tumorigenesis (Q38282726) (← links)